Community

Peyote, Ho-Chunk Healing, and Policy: Indigenous Use and Regulatory Debate

A new study details the Ho-Chunk Nation’s ceremonial peyote practices, offering insight into trauma recovery, cultural resilience, and the ethical complexities facing psychedelic regulation in the U.S.

Published October 12, 2026 Read 3 min 676 words By The Psychedelic Journal

Peyote’s Enduring Role in Ho-Chunk Healing Traditions

Peyote, a psychoactive cactus containing mescaline, has been central to the spiritual and healing practices of the Ho-Chunk Nation and the broader Native American Church (NAC) for over a century. The 2026 study, "Sacred Medicine: Use of Psychogenic Peyote within Ho-Chunk Healing", documents how ceremonial peyote use supports both individual and collective recovery from trauma, including post-traumatic stress disorder (PTSD), substance use disorders, depression, and the effects of cultural oppression. The research underscores that for many Ho-Chunk, peyote ceremonies are not merely therapeutic interventions, but acts of cultural survival and resistance to settler colonialism.

Mechanisms of Healing: Ritual, Community, and Cultural Resilience

Indigenous peyote ceremonies facilitate healing through structured ritual, communal support, and the invocation of ancestral traditions. The study finds that the therapeutic effects reported by Ho-Chunk participants arise from a combination of the psychoactive properties of peyote and the cultural context in which it is used. Unlike Western clinical models, healing is embedded within collective identity and spiritual meaning, with ritual elements—such as prayer, drumming, and storytelling—playing a central role. This approach provides a framework for trauma recovery that integrates mind, body, and community, challenging the assumption that psychedelic efficacy is solely pharmacological.

One insight rarely addressed in mainstream psychedelic discourse is how the communal, non-clinical setting of peyote ceremonies may buffer against certain adverse psychological effects sometimes observed in isolated or recreational contexts. This suggests that the safety and efficacy of psychedelic use are deeply context-dependent, a nuance often overlooked in regulatory and clinical trial design.

Policy and Research Implications: Access, Autonomy, and Legal Protections

The legal status of peyote in the United States is shaped by a complex interplay of federal, state, and tribal law. While the American Indian Religious Freedom Act Amendments of 1994 (AIRFA; Public Law 103-344) federally protect sacramental peyote use by members of federally recognized tribes, access remains restricted for non-Native populations and is subject to state-level variation. The study’s findings inform ongoing debates about religious freedom, indigenous sovereignty, and the ethics of expanding psychedelic access beyond indigenous contexts.

For policymakers, the Ho-Chunk experience highlights the need to distinguish between traditional, culturally anchored psychedelic use and emerging medical or commercial models. Researchers are urged to engage with indigenous knowledge holders and ethical frameworks, recognizing that Western clinical trials may not capture the full spectrum of healing mechanisms at play. As psychedelic regulation evolves—such as Oregon’s psilocybin services and ongoing federal rescheduling discussions—there is increasing pressure to ensure that indigenous practices are protected from appropriation and overregulation.

Risks, Unknowns, and the Limits of Generalization

While the study documents positive outcomes associated with ceremonial peyote use, it cautions against generalizing these effects to non-indigenous or non-ritual contexts. Risks include the potential for cultural appropriation, ecological threats to wild peyote populations, and the imposition of Western regulatory frameworks that may undermine indigenous autonomy. There are also unresolved questions about how best to balance religious freedom with public health concerns, particularly as interest in psychedelic therapies grows among non-Native populations.

Notably, the study does not constitute a randomized controlled trial and does not make clinical treatment claims. Instead, it offers qualitative insights that challenge prevailing assumptions about what constitutes evidence in psychedelic research and policy. This underscores the importance of context-specific risk assessment and the need for ongoing dialogue between indigenous communities, regulators, and researchers.

Looking Ahead: Respect, Collaboration, and Policy Innovation

The Ho-Chunk’s use of peyote provides a living example of how psychedelics can function as sacred medicines, embedded in community and tradition. As the U.S. and other jurisdictions grapple with the future of psychedelic regulation, this study calls for policy approaches that respect indigenous sovereignty, safeguard cultural practices, and recognize the limitations of one-size-fits-all models. Future research should prioritize collaborative, community-led methodologies and support legal frameworks that protect both the medicine and the people who have stewarded its use for generations.

How we research: This article was written and reviewed by Dr. Anna Redbird, PhD (Ho-Chunk Nation, Indigenous Studies), on 2026-10-15. Primary sources include the referenced OpenAlex study and federal legal statutes.

Primary source: https://openalex.org/W7221531883 — referenced for fact-checking; this analysis is independent commentary by the The Psychedelic Journal editorial team.
Found this useful?

Get tomorrow's briefing in your inbox

Policy, research, and regulatory signal — delivered on our publish cadence.

Free. No spam. Unsubscribe anytime.